The Role of Prostaglandins in the Progression of Diabetic Retinopathy and the Therapeutic Efficacy of Topical Ketorolac (Acuvail)
Withdrawn prior to enrolment
Phase of Trial: Phase I
Latest Information Update: 28 Feb 2017
At a glance
- Drugs Ketorolac (Primary)
- Indications Diabetic retinopathy; Retinal disorders
- Focus Pharmacodynamics
- 20 Feb 2017 Status changed from recruiting to withdrawn prior to enrolment.
- 08 Dec 2015 Planned End Date changed from 1 Jan 2016 to 1 Dec 2016, as reported by ClinicalTrials.gov.
- 07 Jan 2014 Planned End Date changed from 1 Mar 2013 to 1 Jan 2016 as reported by clinicalTrials.gov